Belldegrun Arie (CIK 1296549) reported 7 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2025-09-16). Recent activity: Buy LBRX (547,648 shares), Buy LBRX (1,262 shares), Buy LBRX (332,566 shares), Buy LBRX (767 shares), Sell KRON (2.8M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | Insider | Buy | 547,648 | $0 |
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | Insider | Buy | 1,262 | $0 |
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | Insider | Buy | 332,566 | $5.0M |
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | Insider | Buy | 767 | $11,505 |
| 2025-06-20 | Kronos Bio, Inc. (KRON) | Director | Sell | 2.8M | $1.6M |
| 2025-06-20 | Kronos Bio, Inc. (KRON) | Director | Sell | 679,575 | $387,358 |
| 2025-01-28 | Allogene Therapeutics, Inc. (ALLO) | Director | Buy | 369,957 | $0 |
Source: SEC Form 4 filings · as of 2025-09-16